Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial.

OBJECTIVE--To assess the frequency and type of side effects after influenza vaccination in elderly people. DESIGN--Randomised double blind placebo controlled study. SETTING--15 general practices in the southern Netherlands. SUBJECTS--1806 patients aged 60 or older, of whom 904 received influenza vaccine and 902 placebo. MAIN OUTCOME MEASURES--Adverse reactions reported on postal questionnaire completed four weeks after vaccination. RESULTS--210 (23%) patients given vaccine reported one or more adverse reactions compared with 127 (14%) given placebo. The frequency of local adverse reactions were 17.5% in the vaccine group and 7.3% in the placebo group (p < 0.001). There was no difference in systemic adverse reactions (11% v 9.4%; p = 0.34). In general, men reported fewer side effects than women. CONCLUSION--Only local side effects were more common in vaccinated patients and all side effects were mild.

[1]  W. Beyer,et al.  Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers. , 1993, Vaccine.

[2]  K. Nichol,et al.  Influenza vaccination : knowledge, attitudes, and behavior among high-risk outpatients , 1992 .

[3]  A. Palache.  Influenza vaccination : the effect of dose and age on the antibody response : a methodological evaluation of serological vaccination studies. , 1991 .

[4]  J. Desmyter,et al.  [Minority viewpoint on influenza vaccination in the elderly]. , 1991, Nederlands tijdschrift voor geneeskunde.

[5]  K. Upton,et al.  Study into the Ability of Patients with Impaired Lung Function to Use Breath Alcohol Testing Devices , 1991, Medicine, science, and the law.

[6]  K. Nichol,et al.  Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. , 1990, JAMA.

[7]  D. Scheifele,et al.  Evaluation of adverse events after influenza vaccination in hospital personnel. , 1990, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[8]  K. Nichol,et al.  Frequency of adverse reactions after influenza vaccination. , 1990, The American journal of medicine.

[9]  R. Ganguly,et al.  Reasons for Nonimmunization Against Influenza in the Aged , 1989, Journal of the American Geriatrics Society.

[10]  Helliwell Be,et al.  The costs and benefits of preventing influenza in Ontario's elderly. , 1988 .

[11]  M. Drummond,et al.  The costs and benefits of preventing influenza in Ontario's elderly. , 1988, Canadian journal of public health = Revue canadienne de sante publique.

[12]  N. Masurel,et al.  A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection , 1984, Journal of Hygiene.

[13]  J. Kirscht,et al.  Understanding and improving patient compliance. , 1984, Annals of internal medicine.

[14]  J. L. Montagne,et al.  Summary of clinical trials of inactivated influenza vaccine - 1978. , 1983, Reviews of infectious diseases.

[15]  J. Mullooly,et al.  Pneumonia and influenza deaths during epidemics: implications for prevention. , 1982, Archives of internal medicine.

[16]  D. Alling,et al.  A study of excess mortality during influenza epidemics in the United States, 1968-1976. , 1981, American journal of epidemiology.

[17]  J. Mullooly,et al.  Impact of epidemic type A influenza in a defined adult population. , 1980, American journal of epidemiology.

[18]  R. Couch,et al.  Clinical trials of bivalent influenza A/New Jersey/76-A/Victoria/75 vaccines in the elderly. , 1977, The Journal of infectious diseases.

[19]  S. Mostow,et al.  Studies of inactivated influenza virus vaccines in hospital employees: reactogenicity and absenteeism. , 1977, The Journal of infectious diseases.

[20]  G. Noble,et al.  Summary of Clinical Trials of Influenza Vaccines , 1976 .

[21]  G. Jackson,et al.  A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity. , 1972, The Journal of infectious diseases.

[22]  H. S. Kaye,et al.  Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. , 1969, Bulletin of the World Health Organization.